Wave Life Sciences (WVE) Other Working Capital Changes (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Other Working Capital Changes came in at -$1.4 million in Q2 2026, up 80.44% YoY from -$767553.8 in Q2 2025, and up 95.1% on a QoQ basis from -$28.2 million in Q1 2026.
Wave Life Sciences (WVE) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 11 years of Other Working Capital Changes data on file, last reported at -$1.4 million in Q2 2026.
- Quarterly Other Working Capital Changes rose 80.44% year-over-year to -$1.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$33.2 million (up 63.47% YoY) and the FY2025 annual result came in at -$19.8 million, up 78.81% from the prior year.
- Other Working Capital Changes climbed to -$1.4 million in Q2 2026, from -$28.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.8 million in Q1 2023 to a low of -$4.3 million in Q2 2023.
- A 5-year average of -$1.6 million and a median of -$1.7 million in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 8082.83% in 2023, down 27742.38% in 2023.
- Tracing WVE's Other Working Capital Changes over 5 years: stood at -$1.2 million in 2022, then slumped by 543.34% to -$8.0 million in 2023, then tumbled by 932.82% to -$82.3 million in 2024, then surged by 92.75% to -$6.0 million in 2025, then soared by 76.79% to -$1.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q2 2026), -$28.2 million (Q1 2026), and -$6.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.14 Mn |
| Jun 30, 2026 | -2.14 Mn |
| Jun 30, 2026 | -2.14 Mn |
| Mar 31, 2026 | 751,000.00 |
| Mar 31, 2026 | 751,000.00 |
| Mar 31, 2026 | 751,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Mar 31, 2025 | -118,000.00 |
| Dec 31, 2024 | -1.77 Mn |
| Dec 31, 2024 | -1.77 Mn |